|
After a full trial on the merits, the District Court for the Southern District of New York held that the 516 patent was invalid and unenforceable because ICI had deliberately and knowingly withheld material information from the United States Patent and Trademark Office. <a href=http://tamoxifenolvadex.com/>nolvadex d</a>
|
